Target intelligence / Profile preview

Small Cajal body-specific RNA 24 (SCARNA24)

Target: SCARNA24
Molecular classification: Other (non-coding RNA, specifically small Cajal body-specific RNA)

Overview

Small Cajal body-specific RNA 24 (SCARNA24) is a non-coding RNA molecule believed to localize to Cajal bodies within the cell nucleus. It functions as a guide for modifying small nuclear RNAs (snRNAs) involved in pre-mRNA splicing. SCARNA24 does not encode a protein and is not known to be directly involved in disease or targeted by therapeutic drugs[1][3][5].

Other names: LOC124904115small Cajal body-specific RNA 24ENSG00000252274

Biological functions

RNA-guided modification of small nuclear RNA (snRNA), likely involved in pseudouridylation or 2'-O-methylation of spliceosomal snRNAs

Beyond the preview

Go deeper on Small Cajal body-specific RNA 24 (SCARNA24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small Cajal body-specific RNA 24 (SCARNA24).

Explore the full profile